Here’s What Lifted Thermo Fisher Scientific (TMO) in Q3
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here.
Thermo Fisher Scientific Inc. (TMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 2,721,101 | $1,319,789,028 | +2% | 0.48% |
| 2. | Unisphere Establishment Hani Lazkani (Ceo) | 2,060,000 | $999,141,200 | 7.83% | |
| 3. | Generation Investment Management David Blood And Al Gore | 1,284,924 | $623,213,839 | +30% | 4.13% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,266,125 | $614,095,948 | +5% | 0.39% |
| 5. | Farallon Capital Thomas Steyer | 1,258,241 | $610,272,050 | -10% | 2.5% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $535.93 | 4 | $2,143.73 | 14,268 | 2024-12-09 | Filing | |
| $555.89 | 16 | $8,894.24 | 14,264 | 2024-11-07 | Filing | |
| $526.15 | 4 | $2,104.60 | 13,101 | 2023-06-26 | Filing | |
| $134.16 | 1,000 | $134,160.00 | 14,636 | 2015-12-11 | Filing | |
| $45.84 | 36 | $1,650.24 | 25,914 | 2010-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $563.56 | 22,046 | $12,424,243.76 | 84,117 | 2025-12-04 | Filing | |
| $584.11 | 2,521 | $1,472,541.31 | 65,480 | 2025-12-03 | Filing | |
| $583.33 | 29,479 | $17,195,985.07 | 68,001 | 2025-12-03 | Filing | |
| $581.92 | 30,000 | $17,457,600.00 | 29,480 | 2025-12-02 | Filing | |
| $581.94 | 6,912 | $4,022,369.28 | 14,367 | 2025-12-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 95,064 | $55,084,754 | 0.83% | |
| 2. | 52,359 | $30,339,613 | 0.86% | |
| 3. | 53,091 | $26,411,570 | 0.31% | |
| 4. | 25,775 | $14,935,387 | 3.01% | |
| 5. | 8,123 | $4,706,872 | 1.26% |
News See All
BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View
On December 15, Bank of America raised its price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $700 from $650 and kept a Buy rating on the shares.
14 Best Pharma Dividend Stocks to Buy in 2026
For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other developed countries. Branded medicines carry even steeper premiums.
What Makes Thermo Fisher (TMO) a Good Investment Choice?
Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 14 Best S&P 500 Stocks to Buy Now.
14 Best S&P 500 Stocks to Buy Now
The downturn has been sparked by reports of a prominent Oracle investor exiting from one of its data center projects.
Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO)
According to The Fly, on December 2, 2025, Morgan Stanley analyst Kallum Titchmarsh established a price objective of $670, up from $656. He initiated coverage of Thermo Fisher Scientific Inc.
13 Best Nanotechnology Stocks to Buy Now
Nanotechnology is defined by the National Nanotechnology Initiative as the control of matter in the range of 1 to 100 nanometers, where materials have characteristics distinct from those of bulk forms...
What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3?
Harding Loevner, an asset management company, released its “Global Equity Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
